09 May, 2026

The British patient advocates the antitrust regulator to probe drug manufacturers

The UK antitrust regulator was invited by patient defense groups to investigate several major drug manufacturers and their British lobbying organization for “suspects” and “coordinated” efforts to increase the prices of medicines. The backdrop of the complaint was an ongoing row between the pharmaceutical industry and the British government for the compulsory discounts that pharmaceutical […]

1 min read

The second patient dies after obtaining Duchenne’s gene therapy in Sarepta

Andrew Joseph covers health, medicine and biopharmal industry in Europe. You can reach Andrew on signal in Drewqjoseph.45. Sarepta Therapeutics said on Sunday that it interrupted the expeditions of its gene therapy of Duchenne muscular dystrophy for patients who can no longer walk, after the death of a second person who received the treatment. Sarepta […]

1 min read